ResearchRSS3 days ago
SMA patients stick with Evrysdi for years, real-world study finds
A study in Spain found that people with spinal muscular atrophy (SMA) who take Evrysdi, an oral medication, stick with the treatment long-term. All patients in the study continued taking the drug, with some staying on it for over three years. This shows the medication is well-tolerated and patients find it easy to keep using.
WHY IT MATTERSIf you or your child has SMA and are considering Evrysdi, this real-world evidence shows that patients successfully stay on the treatment for years, suggesting it's a practical long-term option with good tolerability.